RVL Pharmaceuticals plc Deferred Income, Current
RVL Pharmaceuticals plc had Deferred Income, Current of $1.05 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredIncomeCurrent · last filed 2023-08-14
- 2023-06-30: Deferred Income, Current $1.05M.
- 2023-03-31: Deferred Income, Current $1.81M.
- 2022-12-31: Deferred Income, Current $1.92M.
- 2022-09-30: Deferred Income, Current $1.24M.
| Period end | Deferred Income, Current | Deferred Income, Current as first filed |
|---|---|---|
| 2023-06-30 | $1.05M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.81M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.92M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $1.24M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $931.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $776.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $67.00K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $206.00K 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $28.00K 10-K · filed 2021-03-30 | |
| 2020-09-30 | $13.00K 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $101.00K 10-K · filed 2020-03-19 | $101.35K 10-Q · filed 2019-08-08 |
| 2017-12-31 | $228.12K 8-K · filed 2019-12-20 |